SS&C Technologies
SSNC
$82.95
+1.01%
SS&C Technologies is a global provider of software products and software-enabled services, primarily serving the financial services industry with solutions for portfolio management, fund administration, trading, and banking, as well as healthcare and virtual data room offerings. The company is a market leader in financial technology, differentiated by its extensive acquisition history, including major deals like DST Systems and Blue Prism, which have expanded its scale and product breadth. Currently, the investor narrative centers on the company's ability to integrate these acquisitions, drive organic growth, and improve margins, while also navigating a high debt load and the integration of AI capabilities from Blue Prism. Recent attention has been on the stock's strong rebound from mid-2026 lows, driven by better-than-expected Q1 results and positive analyst sentiment.…
SSNC
SS&C Technologies
$82.95
Investment Opinion: Should I buy SSNC Today?
Rating: Buy. The thesis is that SSNC's forward PE of 10.7x is deeply undervalued relative to its growth potential, and the company's improving margins and strong cash flow will drive earnings growth. Analyst consensus is Buy with an average target of $92.33, implying 11.3% upside.
Sign up to view all
SSNC 12-Month Price Forecast
The AI assessment is bullish, driven by the significant discount on forward earnings and improving operational metrics. The medium confidence reflects the high debt load and integration risks. If the company delivers on earnings estimates, the stock could re-rate higher. Key developments to watch are Q2 earnings and any updates on Blue Prism integration. A downgrade to neutral would occur if revenue growth slows below 5% or if debt concerns escalate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on SS&C Technologies's 12-month outlook, with a consensus price target around $92.33 and implied upside of +11.3% versus the current price.
Average Target
$92.33
0 analysts
Implied Upside
+11.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$82 - $112
Analyst target range
Analyst coverage includes 9 analysts, with a consensus recommendation of 'Buy' (though the data shows 'none' for recommendation, the actions are predominantly Buy). The average target price is $92.33, implying an upside of 11.3% from the current price of $82.95. The target range is $82.00 to $112.00, with the low target near the current price, suggesting limited downside risk, and the high target implying a 35% upside. The wide spread between low and high targets indicates moderate uncertainty, but the recent ratings actions show a consistent 'Buy' stance from firms like DA Davidson, UBS, and Needham, with no downgrades, reflecting positive sentiment. The high target likely assumes continued margin expansion and successful integration of Blue Prism, while the low target may factor in potential debt-related risks or slower growth.
Bulls vs Bears: SSNC Investment Factors
SSNC presents a mixed picture: strong recent operational performance with Q1 revenue up 8.8% and net margin expansion, but a high debt load and a trailing PE premium to peers. The forward PE of 10.7x suggests the market expects significant earnings growth, likely from cost synergies and margin expansion. However, the stock's 1-year underperformance and high PEG ratio indicate lingering doubts. The bull case is supported by analyst consensus and improving fundamentals, while the bear case hinges on debt and integration risks. The key tension is whether the company can deliver the expected earnings growth to justify the forward multiple, which would resolve the debate in favor of bulls.
Bullish
- Strong Q1 beat and raised guidance: Q1 2026 revenue grew 8.8% YoY to $1.647B, beating expectations, and net income surged to $226.1M with a 13.7% net margin, up from 11.7% in Q4. This momentum drove the stock up 23.8% in the past month, signaling improving fundamentals.
- Forward PE at steep discount: The forward PE of 10.7x is a 51% discount to the industry average of 22x, implying the market expects substantial EPS growth. With analyst EPS estimates at $10.45 for the year, the market is pricing in a major earnings acceleration.
- Robust free cash flow generation: TTM free cash flow stands at $1.71B, with Q1 alone generating $293.7M. This provides ample capacity for debt reduction and shareholder returns, supporting the company's ability to deleverage and invest in growth.
- Analyst consensus Buy with upside: All 9 analysts rate SSNC a Buy, with an average target of $92.33, implying 11.3% upside. The high target of $112 suggests 35% potential, and recent ratings from DA Davidson, UBS, and Needham are all positive.
Bearish
- High debt burden with D/E of 1.11: Debt-to-equity stands at 1.11, and Q1 interest expense was $105.4M, eating into profits. While manageable, rising rates or a downturn could strain cash flows and limit financial flexibility.
- Trailing PE premium to industry: The trailing PE of 26.8x is a 22% premium to the industry average of 22x, suggesting the stock is not cheap on current earnings. If growth disappoints, the multiple could compress.
- Negative 1-year return despite market rally: SSNC is down 6.5% over the past year while the S&P 500 gained 20.5%, underperforming by 27%. This relative weakness indicates persistent investor skepticism about the company's growth prospects.
- High PEG ratio of 4.87: The PEG ratio of 4.87 suggests the stock is overvalued relative to its expected earnings growth. This implies that the market is paying a premium for growth that may not materialize at the expected pace.
SSNC Technical Analysis
SSNC's price trend over the past year has been choppy, with the stock currently trading at $82.95, down 6.48% from a year ago, but well off its 52-week low of $61.40. The stock is now at 91% of its 52-week range (calculated as (82.95-61.40)/(91.07-61.40)), indicating it is near the highs, which suggests strong momentum and bullish sentiment. However, the 1-year negative return contrasts with the recent surge, implying that the stock is recovering from a prior downtrend and may be in the early stages of a new uptrend.
Beta
1.09
1.09x market volatility
Max Drawdown
-31.2%
Largest decline past year
52-Week Range
$61-$91
Price range past year
Annual Return
-6.5%
Cumulative gain past year
| Period | SSNC Return | S&P 500 |
|---|---|---|
| 1m | +23.8% | +3.6% |
| 3m | +23.7% | +2.7% |
| 6m | +16.2% | +11.4% |
| 1y | -6.5% | +18.7% |
| ytd | -3.3% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SSNC Fundamental Analysis
Revenue has been growing steadily, with Q1 2026 revenue of $1.647 billion, up 8.8% year-over-year, and sequential growth from $1.534 billion in Q2 2025. The growth is driven by software-enabled services, which contributed $1.407 billion in the latest quarter, while maintenance and licenses added $212 million. This consistent growth, though moderate, reflects the company's ability to expand its recurring revenue base. Profitability is solid, with Q1 2026 net income of $226.1 million and a net margin of 13.7%, up from 11.7% in Q4 2025. Gross margin improved to 48.7% from 47.7% in the prior quarter, indicating operational leverage. The company is profitable and generating strong cash flow, with free cash flow of $293.7 million in Q1 2026 and $1.71 billion on a TTM basis. However, the balance sheet carries significant debt, with a debt-to-equity ratio of 1.11 and interest expense of $105.4 million in Q1, but the current ratio of 1.07 suggests adequate liquidity.
Quarterly Revenue
$1.6B
2026-03
Revenue YoY Growth
+8.8%
YoY Comparison
Gross Margin
48.7%
Latest Quarter
Free Cash Flow
$1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SSNC Overvalued?
Given positive net income, the PE ratio is the primary valuation metric. The trailing PE is 26.8x, while the forward PE is 10.7x, indicating the market expects significant earnings growth. The gap between trailing and forward PE suggests that analysts anticipate a substantial increase in EPS, likely due to cost synergies from acquisitions and margin expansion. Compared to the industry average PE of 22x (from valuation data), SSNC's trailing PE of 26.8x is a 22% premium, but the forward PE of 10.7x is a 51% discount, implying that the market is pricing in above-average growth. Historically, the stock's PE has ranged from 15.7x to 33.8x over the past few years, with the current trailing PE near the middle of that range, suggesting it is not overvalued relative to its own history. The PS ratio of 3.4x is below the historical average of around 10x, indicating potential undervaluation on a sales basis.
PE
26.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 16x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are prominent: SSNC carries a debt-to-equity ratio of 1.11, with Q1 interest expense of $105.4M, which consumes a significant portion of operating income. While the current ratio of 1.07 indicates adequate liquidity, the high leverage amplifies vulnerability to rising interest rates or a downturn. The company's net margin of 13.7% is solid but could be pressured by integration costs or competitive pricing. Additionally, revenue growth of 8.8% YoY is moderate, and any deceleration could make it difficult to service debt and maintain investor confidence.